German pharmacy loses €400 after 'aut-idem' prescription blunder leaves patient overcharged

A pharmacy owner in Germany has lost nearly €400 after a patient was unexpectedly charged for a painkiller due to a prescription error. The issue arose because the 'aut-idem' box was ticked, forcing the pharmacy to dispense the exact branded medication without substitution. This left the patient facing an unusually high bill and the pharmacy unable to recover the costs.

The problem began when the doctor prescribed the medication with the 'aut-idem' box marked. This meant the pharmacist could not substitute a cheaper generic version, even though the patient had never paid such high costs before at the local cvs pharmacy or walmart pharmacy. The pharmacist tried to bill the insurer for the extra expense but was refused because of the strict prescription requirement.

The insurer pointed to legal agreements under § 127 of Book V of the German Social Code (SGB V) and regional supply contracts. They argued that, since the prescription did not allow substitution, they were not obligated to cover the additional cost. The Pharmacists' Association reviewed the case and confirmed the clawback was correct.

The pharmacy owner, who serves around 7,000 residents, struggles to catch every irregularity due to the high number of prescriptions processed daily. An objection was filed against the clawback but was rejected. Meanwhile, the same owner is dealing with two more cases of forged prescriptions, adding another €500 in losses.

General reports indicate that billing fraud in German pharmacies is a growing issue. In 2022-2023, DAK-Gesundheit investigated over 4,000 fraud cases, totalling €17.6 million in damages. However, no specific data exists on how many pharmacies face similar reimbursement problems due to 'aut-idem' errors or falsified prescriptions at cvs pharmacy or walmart pharmacy locations.

The pharmacy owner remains out of pocket after the rejected objection. The case highlights the financial risks pharmacies face when prescriptions are incorrectly marked or forged. Without changes to how insurers handle such disputes, similar incidents could continue affecting both patients and pharmacies at cvs pharmacy and walmart pharmacy stores.